164 related articles for article (PubMed ID: 15057048)
1. Cutaneous malignant melanoma and neurofibromatosis type 1.
Guillot B; Dalac S; Delaunay M; Baccard M; Chevrant-Breton J; Dereure O; Machet L; Sassolas B; Zeller J; Bernard P; Bedane C; Wolkenstein P;
Melanoma Res; 2004 Apr; 14(2):159-63. PubMed ID: 15057048
[TBL] [Abstract][Full Text] [Related]
2. Iris melanoma in a patient with neurofibromatosis.
Honavar SG; Singh AD; Shields CL; Shields JA; Eagle RC
Surv Ophthalmol; 2000; 45(3):231-6. PubMed ID: 11094247
[TBL] [Abstract][Full Text] [Related]
3. Neurofibromatosis type 1 and melanoma of the iris arising from a dysplastic nevus: A rare yet casual association?
Alessio G; Guerriero S; Albano V; Piscitelli D; Falcone V; Lastella P; Resta N; Stella A
Eur J Ophthalmol; 2021 May; 31(3):NP45-NP49. PubMed ID: 32064917
[TBL] [Abstract][Full Text] [Related]
4. Cutaneous melanoma with neurofibromatosis type 1: rare association? A case report and review of the literature.
Salvi PF; Lombardi A; Puzzovio A; Stagnitti F; Tisba M; Gaudinieri A; Pappalardo G
Ann Ital Chir; 2004; 75(1):91-5. PubMed ID: 15283396
[TBL] [Abstract][Full Text] [Related]
5. A novel diagnostic method to detect truncated neurofibromin in neurofibromatosis 1.
Esposito T; Piluso G; Saracino D; Uccello R; Schettino C; Dato C; Capaldo G; Giugliano T; Varriale B; Paolisso G; Di Iorio G; Melone MA
J Neurochem; 2015 Dec; 135(6):1123-8. PubMed ID: 26478990
[TBL] [Abstract][Full Text] [Related]
6. Clinical genomic profiling identifies TYK2 mutation and overexpression in patients with neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.
Hirbe AC; Kaushal M; Sharma MK; Dahiya S; Pekmezci M; Perry A; Gutmann DH
Cancer; 2017 Apr; 123(7):1194-1201. PubMed ID: 27875628
[TBL] [Abstract][Full Text] [Related]
7. Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR.
Rübben A; Bausch B; Nikkels A
Mol Cancer; 2006 Sep; 5():36. PubMed ID: 16961930
[TBL] [Abstract][Full Text] [Related]
8. Malignant and benign tumors in patients with neurofibromatosis type 1 in a defined Swedish population.
Zöller ME; Rembeck B; Odén A; Samuelsson M; Angervall L
Cancer; 1997 Jun; 79(11):2125-31. PubMed ID: 9179058
[TBL] [Abstract][Full Text] [Related]
9. Allelic loss of the NF1 gene in anal malignant melanoma in a patient with neurofibromatosis type 1.
Ishii S; Han S; Shiiba K; Mizoi T; Okabe M; Horii A; Nagura H; Matsuno S; Sasaki I
Int J Clin Oncol; 2001 Aug; 6(4):201-4. PubMed ID: 11706558
[TBL] [Abstract][Full Text] [Related]
10. Malignant peripheral nerve sheath tumors associated with neurofibromatosis type 1: a clinicopathologic and molecular study of 17 patients.
Leroy K; Dumas V; Martin-Garcia N; Falzone MC; Voisin MC; Wechsler J; Revuz J; Créange A; Levy E; Lantieri L; Zeller J; Wolkenstein P
Arch Dermatol; 2001 Jul; 137(7):908-13. PubMed ID: 11453810
[TBL] [Abstract][Full Text] [Related]
11. Rectal carcinoma and multiple gastrointestinal stromal tumors (GIST) of the small intestine in a patient with neurofibromatosis type 1: a case report.
Hakozaki Y; Sameshima S; Tatsuoka T; Okuyama T; Yamagata Y; Noie T; Oya M; Fujii A; Ueda Y; Shimura C; Katagiri K
World J Surg Oncol; 2017 Aug; 15(1):160. PubMed ID: 28835241
[TBL] [Abstract][Full Text] [Related]
12. The NF1 somatic mutational landscape in sporadic human cancers.
Philpott C; Tovell H; Frayling IM; Cooper DN; Upadhyaya M
Hum Genomics; 2017 Jun; 11(1):13. PubMed ID: 28637487
[TBL] [Abstract][Full Text] [Related]
13. Breast cancer in women with neurofibromatosis type 1 (NF1): a comprehensive case series with molecular insights into its aggressive phenotype.
Yap YS; Munusamy P; Lim C; Chan CHT; Prawira A; Loke SY; Lim SH; Ong KW; Yong WS; Ng SBH; Tan IBH; Callen DF; Lim JCT; Thike AA; Tan PH; Lee ASG
Breast Cancer Res Treat; 2018 Oct; 171(3):719-735. PubMed ID: 29926297
[TBL] [Abstract][Full Text] [Related]
14. Malignant melanoma of the choroid in neurofibromatosis.
Wiznia RA; Freedman JK; Mancini AD; Shields JA
Am J Ophthalmol; 1978 Nov; 86(5):684-7. PubMed ID: 102202
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous melanoma in a patient with neurofibromatosis.
Mastrangelo MJ; Goepp CE; Patel YA; Clark WH
Arch Dermatol; 1979 Jul; 115(7):864-5. PubMed ID: 110269
[TBL] [Abstract][Full Text] [Related]
16. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
17. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
Watson KL; Al Sannaa GA; Kivlin CM; Ingram DR; Landers SM; Roland CL; Cormier JN; Hunt KK; Feig BW; Ashleigh Guadagnolo B; Bishop AJ; Wang WL; Slopis JM; McCutcheon IE; Lazar AJ; Torres KE
J Neurosurg; 2017 Jan; 126(1):319-329. PubMed ID: 27035165
[TBL] [Abstract][Full Text] [Related]
18. Melanoma in individuals with neurofibromatosis type 1: a retrospective study.
Zhang M; Bhat T; Gutmann DH; Johnson KJ
Dermatol Online J; 2019 Nov; 25(11):. PubMed ID: 32045143
[TBL] [Abstract][Full Text] [Related]
19. [Neurofibromatosis von Recklinghausen type 1 (NF1) - clinical picture and molecular-genetics diagnostic].
Petrák B; Bendová Š; Lisý J; Kraus J; Zatrapa T; Glombová M; Zámečník J
Cesk Patol; 2015; 51(1):34-40. PubMed ID: 25671360
[TBL] [Abstract][Full Text] [Related]
20. [Type 1 neurofibromatosis. Molecular and clinical aspects].
Schweigerer L
Hautarzt; 1996 Aug; 47(8):591-8. PubMed ID: 8964700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
